• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

灌注大鼠心肌中锝99m-Q12的动力学:缺氧和低流量的影响。

Technetium 99m-Q12 kinetics in perfused rat myocardium: effects of hypoxia and low flow.

作者信息

Okada R D, Nguyen K N, Lauinger M, Allton I L, Johnson G

机构信息

William K Warren Medical Research Institute of the University of Oklahoma Health Sciences Center, Tulsa, OK 74136, USA.

出版信息

Am Heart J. 1996 Jul;132(1 Pt 1):108-15. doi: 10.1016/s0002-8703(96)90397-x.

DOI:10.1016/s0002-8703(96)90397-x
PMID:8701850
Abstract

Technetium 99m-Q12 is a new cationic myocardial perfusion imaging agent that produces excellent images in human beings. The purpose of this study was to examine the separate effects of hypoxia and low flow on myocardial clearance kinetics. After a 1 mCi bolus injection, myocardial 99mTc-Q12 clearance was monitored for 1 hour by using an Nal detector in 24 isolated perfused rat hearts. In 6 control hearts, flow was 12 ml/min, and oxygenation was normal. In 6 hypoxic hearts, flow was normal, but oxygenation was reduced (<5% 02). In 6 low-flow hearts, flow was 3 ml/min, and oxygenation was normal. In 6 very low flow hearts, flow was 1 ml/min, and oxygenation was normal. 99mTc-Q12 myocardial clearance was biphasic in all four groups, consisting of a rapid early phase and a second slow phase that began after 10 minutes. Myocardial retention between 1 and 10 minutes was 56.8% +/- 1.8% for control, 49.2% +/- 2.2% (p < 0.05 compared with control) for hypoxic, 56.8% +/- 2.6% (p = NS compared with control) for low flow (3 ml/min), and 63.7% +/- 2.1 % (p < 0.05 compared with control) for very low flow hearts (1 ml/min). Myocardial retention between 10 and 60 minutes was 90.5% +/- 0.2% for control, 90.2% +/- 1.6% for hypoxic, 90.0% +/- 0.8% for low-flow hearts (3 ml/min), and 87.6% +/- 0.3% (p < 0.05 compared with other groups) for very low flow hearts (1 ml/min). In conclusion, 99mTc-012 demonstrates biphasic clearance from normal, hypoxic, low-flow, and very low flow ischemic myocardium. Early-phase myocardial retention is decreased by hypoxia and increased by very low flow.

摘要

锝99m - Q12是一种新型阳离子心肌灌注显像剂,能在人体中产生优质图像。本研究的目的是研究缺氧和低灌注对心肌清除动力学的单独影响。在24个离体灌注大鼠心脏中,经静脉团注1毫居里后,使用碘化钠探测器监测心肌对99mTc - Q12的清除情况,持续1小时。6个对照心脏,灌注流量为12毫升/分钟,氧合正常。6个缺氧心脏,灌注流量正常,但氧合降低(氧含量<5%)。6个低灌注心脏,灌注流量为3毫升/分钟,氧合正常。6个极低灌注心脏,灌注流量为1毫升/分钟,氧合正常。四组中99mTc - Q12心肌清除均呈双相,包括快速的早期相和10分钟后开始的第二缓慢相。1至10分钟心肌滞留率,对照组为56.8%±1.8%,缺氧组为49.2%±2.2%(与对照组相比,p<0.05),低灌注(3毫升/分钟)组为56.8%±2.6%(与对照组相比,p =无显著差异),极低灌注(1毫升/分钟)组为63.7%±2.1%(与对照组相比,p<0.05)。10至60分钟心肌滞留率,对照组为90.5%±0.2%,缺氧组为90.2%±1.6%,低灌注(3毫升/分钟)组为90.0%±0.8%,极低灌注(1毫升/分钟)组为87.6%±0.3%(与其他组相比,p<0.05)。总之,99mTc - Q12在正常、缺氧、低灌注和极低灌注缺血心肌中的清除呈双相。缺氧会降低早期心肌滞留率,极低灌注会增加早期心肌滞留率。

相似文献

1
Technetium 99m-Q12 kinetics in perfused rat myocardium: effects of hypoxia and low flow.灌注大鼠心肌中锝99m-Q12的动力学:缺氧和低流量的影响。
Am Heart J. 1996 Jul;132(1 Pt 1):108-15. doi: 10.1016/s0002-8703(96)90397-x.
2
Effects of no flow and reperfusion on technetium-99m-Q12 kinetics.无血流和再灌注对锝-99m-Q12动力学的影响。
J Nucl Med. 1995 Nov;36(11):2103-9.
3
Monocationic radiotracer kinetics and myocardial infarct size: a perfused rat heart study.单阳离子放射性示踪剂动力学与心肌梗死面积:一项灌注大鼠心脏研究。
Ann Nucl Med. 2008 Aug;22(7):617-27. doi: 10.1007/s12149-008-0155-y. Epub 2008 Aug 29.
4
Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia.低流量、缺氧及无糖血症状态下99m锝葡糖醛酸的心肌动力学
J Nucl Cardiol. 2003 Mar-Apr;10(2):168-76. doi: 10.1067/mnc.2003.1.
5
Myocardial kinetics of 99m technetium-Q agents: studies in isolated cardiac myocyte, isolated perfused rat heart, and canine regional myocardial ischemia models.99m锝-Q制剂的心肌动力学:在分离的心肌细胞、离体灌注大鼠心脏及犬局部心肌缺血模型中的研究
Invest Radiol. 1999 Nov;34(11):704-17. doi: 10.1097/00004424-199911000-00007.
6
Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia.在冠状动脉酸血症期间,分离的大鼠心脏对锝-99m Q12、锝-99m 甲氧基异丁基异腈和铊-201的摄取与保留
Eur J Nucl Med. 1997 Dec;24(12):1479-86. doi: 10.1007/s002590050177.
7
Kinetic properties of 99mTc-Q12 in canine myocardium.
Circulation. 1994 Mar;89(3):1291-300. doi: 10.1161/01.cir.89.3.1291.
8
HL-91-technetium-99m: a new marker of viability in ischemic myocardium.HL-91-锝-99m:缺血心肌存活的新标志物。
J Nucl Cardiol. 1999 May-Jun;6(3):306-15. doi: 10.1016/s1071-3581(99)90043-0.
9
Effects of low flow and hypoxia on myocardial retention of technetium-99m BMS181321.低流量和低氧对心肌滞留锝-99m BMS181321的影响。
Eur J Nucl Med. 1996 Apr;23(4):443-7. doi: 10.1007/BF01247374.
10
Kinetics of technetium-99m-teboroxime in reperfused nonviable myocardium.锝-99m-特硼肟在再灌注的无活性心肌中的动力学。
J Nucl Med. 1997 Feb;38(2):274-9.